Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul 7:5:48.
doi: 10.1186/1746-1596-5-48.

Tissue microarrays: one size does not fit all

Affiliations

Tissue microarrays: one size does not fit all

Jeanette E Eckel-Passow et al. Diagn Pathol. .

Abstract

Background: Although tissue microarrays (TMAs) are commonly employed in clinical and basic-science research, there are no guidelines for evaluating the appropriateness of a TMA for a given biomarker and tumor type. Furthermore, TMA performance across multiple biomarkers has not been systematically explored.

Methods: A simulated TMA with between 1 and 10 cores was designed to study tumor expression of 6 biomarkers with varied expression patterns (B7-H1, B7-H3, survivin, Ki-67, CAIX, and IMP3) using 100 patients with clear cell renal cell carcinoma (RCC). We evaluated agreement between whole tissue section and TMA immunohistochemical biomarker quantification to assess how many TMA cores are necessary to adequately represent RCC whole tissue section expression. Additionally, we evaluated associations of whole tissue section and TMA expression with RCC-specific death.

Results: The number of simulated TMA cores necessary to adequately represent whole tissue section quantification is biomarker specific. Although 2-3 cores appeared adequate for B7-H3, Ki-67, CAIX, and IMP3, even as many as 10 cores resulted in poor agreement for B7-H1 and survivin compared to RCC whole tissue sections. While whole tissue section B7-H1 was significantly associated with RCC-specific death, no significant associations were detected using as many as 10 TMA cores, suggesting that TMAs can result in false-negative findings if the TMA is not optimally designed.

Conclusions: Prior to TMA analysis, the number of TMA cores necessary to accurately represent biomarker expression on whole tissue sections should be established as there is not a one-size-fits-all TMA. We illustrate the use of a simulated TMA as a cost-effective tool for this purpose.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Simulated TMA template mask. (A) 19 equally spaced 0.6 mm viewing ports and the TMA template placed below the objective of a microscope, and (B) the order of the 10 cores used for quantification of tumor biomarker expression.
Figure 2
Figure 2
Box plots illustrating Wald chi-square statistics from 500 bootstrap samples. Testing associations of (A) B7-H3, (B) survivin, (C) Ki-67, (D) CAIX, (E) IMP3, and (F) B7-H1 expression with RCC-specific death using 1 and up to 10 cores. The lower, middle, and upper horizontal lines that comprise the boxes denote the 25th percentile, median, and 75th percentile of the distribution of test statistics from the 500 bootstrap samples. Using a significance level of 0.05, the critical value for a 1 degree-of-freedom chi-square test statistic is approximately 3.8. B7-H1 was modeled as dichotomous (positive versus negative), whereas B7-H3, survivin, Ki-67, CAIX, and IMP3 were modeled as continuous.

References

    1. Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S, Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844–847. doi: 10.1038/nm0798-844. - DOI - PubMed
    1. Giltnane JM, Rimm DL. Technology insight: identification of biomarkers with tissue microarray technology. Nat Clin Pract Oncol. 2004;1:104–111. doi: 10.1038/ncponc0046. - DOI - PubMed
    1. Simon R, Mirlacher M, Sauter G. Tissue microarrays in cancer diagnosis. Expert Rev Mol Diagn. 2003;3:421–430. doi: 10.1586/14737159.3.4.421. - DOI - PubMed
    1. Hager M, Kolbitsch C, Tiefenthaler W, Haufe H, Kemmerling R, Moser PL. Tissue microarrays from renal cell tumors: exclusion criteria and rate of exclusion. Scand J Urol Nephrol. 2007;41:485–489. doi: 10.1080/00365590701520552. - DOI - PubMed
    1. Fons G, Hasibuan SM, van der Velden J, ten Kate FJW. Validation of tissue microarray technology in endometrioid cancer of the endometrium. J Clin Pathol. 2007;60:500–503. doi: 10.1136/jcp.2006.040170. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances